AXSM Financials
Axsome Therapeutics Inc - Financial statements & key metrics
Stock Price
$205.00
Market Cap
$11.96B
P/E Ratio
-34.2
EPS
$-4.67
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$385.69M
Gross Profit
-
Operating Income
-
Net Income
$-287.22M
EPS (Diluted)
$-5.99
Balance Sheet Highlights
Total Assets
$568.50M
Total Liabilities
$511.48M
Shareholders Equity
-
Cash & Equivalents
$315.35M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-128.41M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-19.3%
Net Margin
-40.9%
ROE
-275.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AXSM revenue?
AXSM's most recent quarterly revenue was $385.69M. Annual revenue can be calculated by summing the four most recent quarters.
Is AXSM profitable?
AXSM reported a loss of $287.22M in the most recent quarter. The net profit margin is -40.9%.
What is AXSM market cap?
AXSM has a market capitalization of $11.96B, making it a large-cap stock.
Does AXSM have debt?
View AXSM's balance sheet for debt information.
What is AXSM cash flow?
Cash flow data is available in the full financial statements.